How long does Saxenda stay in your body after your last injection? Saxenda (liraglutide 3.0 mg) is a GLP-1 receptor agonist prescribed for weight management in the UK. Understanding its duration in your system is essential for managing treatment expectations, planning dosing schedules, and recognising when its effects diminish. With a half-life of approximately 13 hours, Saxenda is effectively eliminated within about 3 days of discontinuation. This article explains the pharmacokinetics of Saxenda, factors affecting elimination, and what to expect when stopping treatment, aligned with UK guidance from NICE and the MHRA.

What Is Saxenda and How Does It Work?

Saxenda (liraglutide 3.0 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity or those who are overweight with weight-related health conditions. It belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists, which were originally developed for type 2 diabetes management but have proven effective for weight loss at higher doses.

The active ingredient, liraglutide, works by mimicking a naturally occurring hormone called GLP-1 that is released in the gut after eating. This hormone plays several important roles in regulating appetite and metabolism. Saxenda acts on specific receptors in the brain that control hunger and satiety, helping you feel fuller for longer periods and reducing overall food intake. Additionally, it slows gastric emptying—the rate at which food leaves the stomach—which contributes to prolonged feelings of fullness after meals.

Saxenda is administered as a once-daily subcutaneous injection using a pre-filled pen device, typically injected into the abdomen, thigh, or upper arm. The dose is gradually increased over five weeks to minimise gastrointestinal side effects, starting at 0.6 mg daily and building up to the maintenance dose of 3.0 mg daily. According to the Saxenda Summary of Product Characteristics (SmPC), treatment should only be continued if patients achieve at least 5% weight loss after 12 weeks of treatment at the full 3.0 mg daily dose.

It is important to understand that Saxenda is not a standalone solution for weight loss. It must be used alongside a reduced-calorie diet and increased physical activity as part of a comprehensive weight management programme. On the NHS, Saxenda is available through specialist weight management services for people meeting specific BMI and risk factor criteria as defined by NICE guidance (TA664). It is also available privately through registered healthcare professionals following appropriate clinical assessment. Saxenda should not be used with other GLP-1 receptor agonists, for type 1 diabetes, or as a substitute for insulin.

How Long Does Saxenda Stay in Your System?

Understanding how long Saxenda remains in your body is important for managing treatment expectations, planning dose schedules, and understanding potential side effects. The duration a medication stays in your system is measured using a pharmacological concept called half-life—the time it takes for half of the drug to be eliminated from your bloodstream.

Saxenda has a half-life of approximately 13 hours following subcutaneous injection. This means that roughly 13 hours after your injection, about half of the liraglutide dose will have been metabolised and cleared from your circulation. However, this does not mean the drug is completely eliminated after 13 hours. It typically takes five to six half-lives for a medication to be almost entirely cleared from the body.

Based on this pharmacokinetic profile, Saxenda is effectively eliminated from your system within approximately 3 days (65–78 hours) after your last injection. After this period, liraglutide concentrations fall below clinically significant levels. This relatively short elimination time is one reason why Saxenda requires daily dosing to maintain therapeutic blood levels and continue its appetite-suppressing effects.

The medication reaches steady-state concentrations—where the amount administered equals the amount eliminated—after approximately 2-3 days of consistent dosing at each dose level. This means it takes about 2-3 days at each dose step for Saxenda to reach stable levels in your body, with the full therapeutic effect building gradually during the 5-week dose titration period. Conversely, if you stop taking Saxenda, you can expect its effects on appetite and gastric emptying to diminish within a similar timeframe as the drug clears your system. This pharmacokinetic profile differs from some other weight management medications that may have longer or shorter durations of action.

Factors That Affect How Long Saxenda Remains in Your Body

While the average half-life of Saxenda is approximately 13 hours, several individual factors can influence how quickly or slowly your body processes and eliminates the medication. Understanding these variables helps explain why people may experience different durations of effect or side effects.

Kidney function plays a role in drug elimination. According to the Saxenda SmPC, no dose adjustment is generally needed for mild to moderate renal impairment. However, there is limited experience in patients with severe renal impairment or end-stage renal disease, so Saxenda is not recommended in these groups. It's important to maintain adequate hydration while taking Saxenda, as dehydration (from side effects like nausea, vomiting or diarrhoea) could potentially lead to acute kidney injury.

Liver function affects drug metabolism differently than might be expected. Clinical studies show that exposure to liraglutide actually decreases with worsening hepatic impairment. While no dose adjustment is recommended for mild to moderate hepatic impairment, Saxenda is not recommended for patients with severe hepatic impairment due to limited clinical experience in this group.

Age can influence drug metabolism, with older adults sometimes experiencing different clearance rates due to age-related changes in organ function and body composition. However, clinical trials have not identified the need for routine dose adjustments based on age alone.

Body weight and composition may also affect drug distribution, though Saxenda dosing is not weight-adjusted. Additionally, injection site and technique can influence absorption rates—injecting into areas with more subcutaneous fat or poor circulation may affect absorption slightly.

Regarding drug interactions, liraglutide has no significant interactions involving cytochrome P450 enzymes. However, the transient slowing of gastric emptying may affect the absorption of some oral medicines. For medications with a narrow therapeutic index (such as warfarin), monitoring (e.g., INR for warfarin) may be advisable when starting or stopping Saxenda. If you have concerns about how these factors might affect your treatment, discuss them with your prescribing healthcare professional.

What Happens When You Stop Taking Saxenda?

When you discontinue Saxenda treatment, it is important to understand both the immediate pharmacological effects and the longer-term implications for weight management. As discussed, the medication clears from your system within approximately 3 days of your last injection, and the physiological effects diminish accordingly during this period.

Appetite changes are typically the first noticeable effect after stopping Saxenda. As liraglutide levels decline, the GLP-1 receptor stimulation that suppressed hunger signals gradually wanes. Many patients report a return of appetite within several days, often experiencing increased hunger compared to when they were on treatment. Gastric emptying returns to normal rates, meaning you may feel less full after meals than you did while taking the medication.

Weight regain is a significant concern after discontinuing Saxenda. Clinical trial data, including the SCALE Obesity and Prediabetes extension studies, consistently show that many patients regain some or all of the weight they lost whilst on treatment if they do not maintain lifestyle modifications. Research indicates that without continued dietary changes and physical activity, weight regain often begins within weeks of stopping the medication. This occurs because Saxenda addresses the physiological drivers of obesity but does not cure the underlying condition.

There is no official withdrawal syndrome associated with stopping Saxenda, and you can discontinue treatment abruptly without tapering the dose. However, some patients report temporary digestive changes as their system readjusts. Side effects experienced during treatment, such as nausea or gastrointestinal discomfort, typically resolve within a few days of stopping.

If you are considering stopping Saxenda, discuss this decision with your GP or prescribing clinician. They can help you develop a plan to maintain weight loss through continued lifestyle modifications, dietary support, and potentially alternative weight management strategies.

It's important to seek urgent medical advice if you experience severe, persistent abdominal pain (with or without vomiting) which could suggest pancreatitis, or if you develop symptoms of gallbladder disease. If you become pregnant while taking Saxenda, you should stop the medication and contact your prescriber immediately, as it is not recommended during pregnancy or breastfeeding. Any suspected side effects can be reported through the MHRA Yellow Card scheme.

Frequently Asked Questions